Welcome to the CRL Insurer Services blog! Here you will find commentary from our dedicated team of medical directors and industry leaders on lab research and trends, innovative services and solutions, and what’s new at CRL. Click the button below to get the latest news directly to your inbox. Questions? Contact us at ILSsales@crlcorp.com.
Dr. Michael Fulks, Consulting Medical Director, details a new study showcasing improved outcomes for pancreatic cancer patients through the use… Read More
Tags: Cancer, Life Insurance, Pancreatic cancer, Study
Consulting medical director Michael Fulks, MD, comments on recent changes to the leading causes of death because of COVID-19, drugs,… Read More
Tags: Cancer, Covid 19, Drug overdose, Life Insurance, Mortality
Recently Dr. Michael Fulks commented on 2020 mortality data from JAMA, citing an increase of 17.7% from 2019 to 2020… Read More
Tags: Cancer, Insurance, Life Insurance, Mortality, Retirement
Dr. Michael Fulks, Consulting Medical Director to CRL, comments on the 2020 leading causes of death in a COVID-19 world…. Read More
Tags: Cancer, Covid 19, Heart Disease, Life Insurance, Mortality
How do you find a very expensive early mortality risk, most of which is the result of undiagnosed — but… Read More
Tags: Cancer, Lab Tests, Life Insurance, Mortality, Underwriting
In a recent Journal of Insurance Medicine article¹, Drs. Rigatti and Stout used data from over 300,000 individuals who had… Read More
Tags: Cancer, Doctors, Life Insurance, Mortality, Underwriting
What to do about an elevated PSA value that is newly found on insurance screening or under “active surveillance”? We… Read More
Tags: Cancer, Life Insurance, Mortality, Prostate, Underwriting
If you would like to sign up to receive email updates from the Insurer team, please click here.